Abstract: This invention is based upon the finding that certain chlorosulfonated ?-olefin copolymers can be beneficially utilized in drilling fluids that are utilized in drilling subterreanean wells. For instance, it has been unexpectedly found that certain chlorosulfonated ?-olefin copolymers can be beneficially used as total or partial replacements for organoclays in oil based drilling fluids.

Abstract: Novel benzoxazine-thiol adducts are described, which may be may be cured to produce compositions useful in coating, sealants, adhesive and many other applications.

Abstract: Enhanced oil recovery method consisting in continuously dissolving, in the injection water, a stable invert emulsion of acrylamide (co)polymer containing at least one inverting agent, and a water soluble polymer, whereby: in a first step, the emulsion is prediluted in a first static mixer to a (co)polymer concentration of at least 5 g/l, the difference of pressure between the mixer outlet and inlet being at least 2 bar, in a second step, the suspension from the first mixer is diluted in a second static mixer to a concentration corresponding to the injection concentration of the water in the well of between 500 and 3000 ppm, the difference of pressure between the mixer outlet and inlet being at least 1 bar.

Abstract: Novel benzoxazine-thiol adducts are described, which may be may be cured to produce compositions useful in coating, sealants, adhesive and many other applications.

Abstract: Lubricous coatings, methods for making and using lubricous coatings, and medical device that include lubricious coatings. An example lubricous coating may include a hydrophilic polymer, a flow modifier, an acrylic monomer, a photoinitiator, and a solvent. The coating can be used to coat a medical device along an inner surface, an outer surface, or an intermediate surface.

Abstract: This invention relates to hydroxy alkyl isocyanurates, coating compositions comprising hydroxy alkyl isocyanurates and methods for producing hydroxy alkyl isocyanurates. Dried and cured coating compositions containing the hydroxy alkyl isocyanurates provide excellent durability, gloss and distinctness of image.

Abstract: The invention provides a process for the production of a granule of a coated oxidizing compound which granule has good delayed release properties, said process comprising a) providing cores of an oxidizing compound produced by fluidized bed spray granulation, b) spraying on the oxidizing compound cores an aqueous solution of metal sili-cate in a fluidized bed, said aqueous solution comprising at least 15% by weight metal silicate, and c) drying to form a metal silicate coating layer on the oxidizing compound core, provided that the amount of metal silicate coating layer is at least 8%, preferably at least 10% by weight based on the total weight of the granule. The invention also provides such granule and well treatment fluids including such granule, and processes for use.

Abstract: Various embodiments provide a photosensitive siloxane composition containing (a) polysiloxane, (b) a quinone diazide compound, (c) a solvent, and (d) one or more kinds of specified imidosilane compounds. Various embodiments also provide a cured film obtained by applying and/or patterning the photosensitive siloxane composition. Various embodiments further provide a device including the cured film.

Abstract: One or more compositions and methods for inhibiting the formation of hydrate agglomerates in a fluid that contain a specified generic formula are disclosed. The fluid can be contained in an oil or gas pipeline or refinery.

Abstract: One or more compositions and methods for inhibiting the formation of hydrate agglomerates in an aqueous medium that contain a specified generic formula are disclosed. The aqueous medium can be contained in an oil or gas pipeline or refinery.

Abstract: A method for electrostatic coating of medical devices such as stents and balloons is described. The method includes applying a composition to a polymeric component of a medical device which has little or no conductivity. The polymeric component could be a material from which the body or a strut of the stent is made or could be a polymeric coating pre-applied on the stent. The polymeric component could be the balloon wall. A charge can then be applied to the polymeric component or the polymeric component can be grounded. Charged particles of drugs, polymers, biobeneficial agents, or any combination of these can then be electrostatically deposited on the medical device or the coating on the medical device. One example of the composition is iodine, iodine, iodide, iodate, a complex or salt thereof which can also impart imaging capabilities to the medical device.

Abstract: This invention relates to novel chemical resistant, film forming, and moisture vapor permeable ionomers, including specialized polyurethane ionomers, polyurea ionomers, polyamide ionomers, polyester ionomers, or a mixture of the said ionomers, having high content of covalent-bonded ionic groups, total >100 milli-equivalents per 100 gram of ionomers. These specialized ionomers have low noxious chemical crossover rate, high moisture vapor transmission rate, hydrolytically stable in humid environment, and capable of forming thin films.

Abstract: A system and method for coating an endoprosthesis involves an applicator capable of delivering a coating substance to the endoprosthesis without spraying. The applicator may have a tube or die through which a coating substance is moved upwards by capillary action or by means of a pump so as to form an accumulation of the coating substance at an upper portion of the applicator. The endoprosthesis can be lowered onto the accumulation, then axially translated or rotated in order to transfer the coating substance to selected portions of the endoprosthesis. The applicator is lowered and/or the endoprosthesis is raised in order to form gaps in the coating. Selective coating of abluminal or luminal surface of the endoprosthesis may also be performed by allowing the surface to skip on a liquid surface of a pool of the coating substance.

Abstract: A process for reducing solvent contents in drug-containing polymeric compositions may be utilized to reduce the solvent content in implantable medical device wherein the compositions are in reservoirs. Specifically, the solvent contents in the drug-containing polymeric compositions are first reduced by one or more conventional drying methods, to a range from about 0.5 weight percent to about 10 weight percent of the total weight of the polymeric composition. Subsequently, the drug-containing polymeric compositions are further treated by a low temperature drying method for further reduction of the solvent content.

Abstract: The invention, relates to azo-compounds of formula (I), wherein >N—O—R substituted 2,2,6,6-tetraalkyl-piperidyl groups are present. These azo-compounds have excellent flame retardant properties, either if applied alone, or combined with other compounds, having flame retardant properties.

Abstract: Lost circulation of drilling fluid is one of the most serious and expensive problems facing the drilling industry. The present invention relates to an improved drilling fluid for reducing or preventing lost circulation to an underground formation surrounding a well bore in the process of drilling a well. The drilling fluid comprises a base fluid and wax or waxy substance as a primary seepage loss agent. In a particularly preferred embodiment, the seepage loss agent does not include particles having a blend of natural wax and synthetic wax together in a single particle. The invention also provides a method of reducing or preventing lost circulation to an underground formation surrounding a well bore in the process of drilling a well using the drilling fluid of the invention, wherein the primary seepage loss agent is added to the drilling fluid, either before or during drilling, and the drilling fluid is pumped down hole during drilling.

Abstract: The present invention is a novel block copolymer containing a controlled distribution copolymer block of a conjugated diene and a mono alkenyl arene, where the controlled distribution copolymer block has terminal regions that are rich in conjugated diene units and a center region that is rich in mono alkenyl arene units. Also disclosed is a method for manufacture of the block copolymer.

Abstract: Methods for making medical devices having porous coatings. Methods may comprise providing a tubing section having inner and outer surfaces and positioning a nozzle proximate to a target surface of the parent tubing section. A powder form of the porous coating may be delivered toward the tubing section, and a laser may be directed at the powder to melt the powder to form a melt pool. The melt pool can solidify to form the porous coating on the target surface. Portions of the parent tubing section may then be cut away to form the support structure of the medical device, such as a stent.

Abstract: A method for modifying silk polymer by coupling a chemical moiety to a tyrosine residue of a silk polymer is described herein for the purpose of altering the physical properties of the silk protein. Thus, silk proteins with desired physical properties can be produced by the methods described herein. These methods are particularly useful when the introduction of cells to a mammal is desired, since modifications to the silk protein affect the physical properties and thus the adhesion, metabolic activity and cell morphology of the desired cells. The silk protein can be modified to produce, or modify, a structure that provides an optimal environment for the desired cells.

Abstract: Scale inhibiting particulates formed from a mixture of fly ash and a phosphonic acid curing agent; wherein the fly ash is cured into a solid material by the contact with the phosphonic acid curing agent. The mixture may also contain a multivalent ion and the particulates may be coated with a coating material in an amount from about 0.1% to about 40% coating material by weight of the scale inhibiting particulate to delay the release of the scale inhibitor.